Valve replacement in children with functionally univentricular hearts remains challenging. The absence of small prostheses, the lack of growth, and the need for anticoagulation limit these procedures. We describe a 1-year follow-up of an extracellular matrix scaffold tube used as systemic atrio-ventricular valve in an infant.
Keywords: Bioengineered tissue; Congenital heart disease; Univerticular heart; Valve replacement.
Copyright © 2015 Elsevier Inc. All rights reserved.